Evidence map›Paper›PMID 24019479›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Polyclonal hyper-IgE mouse model reveals mechanistic insights into antibody class switch recombination.

Shahram Misaghi, Kate Senger, Tao Sai, Yan Qu, Yonglian Sun, Kajal Hamidzadeh, Allen Nguyen, Zhaoyu Jin, Meijuan Zhou, Donghong Yan and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. IgE Glycosylation in Health and Disease.Current topics in microbiology and immunology · 2019
    Review
  3. Article
  4. Review
  5. Regulation of IgE Responses by γδ T Cells.Current allergy and asthma reports · 2015
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Shahram MisaghiGenentech, Inc., South San Francisco, CA 94080.
Kate Senger
Tao Sai
Yan Qu
Yonglian Sun
Kajal Hamidzadeh
Allen Nguyen
Zhaoyu Jin
Meijuan Zhou
Donghong Yan
Wei Yu Lin
Zhonghua Lin
Maria N Lorenzo
Andrew Sebrell
Jiabing Ding
Min Xu
Patrick Caplazi
Cary D Austin
Mercedesz Balazs
Merone Roose-Girma
Laura DeForge
Søren Warming
Wyne P Lee
Vishva M Dixit
Ali A Zarrin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preceding antibody constant regions are switch (S) regions varying in length and repeat density that are targets of activation-induced cytidine deaminase. We asked how participating S regions influence each other to orchestrate rearrangements at the IgH locus by engineering mice in which the weakest S region, Sε, is replaced with prominent recombination hotspot Sμ. These mice produce copious polyclonal IgE upon challenge, providing a platform to study IgE biology and therapeutic interventions. The insertion enhances ε germ-line transcript levels, shows a preference for direct vs. sequential switching, and reduces intraswitch recombination events at native Sμ. These results suggest that the sufficiency of Sμ to mediate IgH rearrangements may be influenced by context-dependent cues.

Indexed as

Recombination, GeneticAllelesAnimalsB-LymphocytesGene Knock-In TechniquesGene TargetingGenetic LociGerm CellsHybridomasImmunoglobulin Class SwitchingImmunoglobulin EImmunoglobulin epsilon-ChainsImmunoglobulin mu-ChainsLymphocyte ActivationMiceModels, AnimalImmunoglobulin EImmunoglobulin epsilon-ChainsImmunoglobulin mu-ChainsRNA, MessengerAICDAallergyasthmagermline transcriptionimmunoglobulin

Identifiers

PMID24019479
PMCPMC3785764
OpenAlexW2077120272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.